Dr. Francis Collins, director of the National Institutes of Health, says millions of people in high-risk groups will likely “start rolling up their sleeves” to get a COVID-19 vaccine soon.
An advisory committee to the Food and Drug Administration is meeting on Thursday to talk about the Pfizer vaccine. The same committee of scientists and health experts will meet again on Dec. 17 to talk about the Moderna vaccine. Both vaccines have been highly effective in trials, according to the companies.
“If they vote to approve, which most of us believe they will get based on the data we’ve seen so far, then vaccinations could start quite shortly after that,” Collins told Noel King on NPR’s Morning Edition.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
